Literature DB >> 10974016

Genetic and environmental effects in paroxysmal nocturnal hemoglobinuria: this little PIG-A goes "Why? Why? Why?".

N S Young1, J P Maciejewski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10974016      PMCID： PMC381297          DOI： 10.1172/JCI11002

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  20 in total

Review 1.  The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated.

Authors:  N S Young
Journal:  Blood       Date:  1992-03-15       Impact factor: 22.113

2.  Biosynthesis and function of LFA-3 in human mutant cells deficient in phosphatidylinositol-anchored proteins.

Authors:  N Hollander; P Selvaraj; T A Springer
Journal:  J Immunol       Date:  1988-12-15       Impact factor: 5.422

3.  HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine.

Authors:  A Asea; S K Kraeft; E A Kurt-Jones; M A Stevenson; L B Chen; R W Finberg; G C Koo; S K Calderwood
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

4.  Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.

Authors:  D E Dunn; P Tanawattanacharoen; P Boccuni; S Nagakura; S W Green; M R Kirby; M S Kumar; S Rosenfeld; N S Young
Journal:  Ann Intern Med       Date:  1999-09-21       Impact factor: 25.391

5.  Impaired growth and elevated fas receptor expression in PIGA(+) stem cells in primary paroxysmal nocturnal hemoglobinuria.

Authors:  R Chen; S Nagarajan; G M Prince; U Maheshwari; L W Terstappen; D R Kaplan; S L Gerson; J M Albert; D E Dunn; H M Lazarus; M E Medof
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

6.  Expression of decay-accelerating factor on hematopoietic progenitors and their progeny cells grown in cultures with fractionated bone marrow cells from normal individuals and patients with paroxysmal nocturnal hemoglobinuria.

Authors:  K Okuda; A Kanamaru; E Ueda; T Kitani; N Okada; H Okada; E Kakishita; K Nagai
Journal:  Exp Hematol       Date:  1990-11       Impact factor: 3.084

Review 7.  Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine.

Authors:  N Frickhofen; S J Rosenfeld
Journal:  Semin Hematol       Date:  2000-01       Impact factor: 3.851

8.  Cytotoxicity against lymphoblastoid cells mediated by a T-cell clone from an aplastic anaemia patient: role of CD59 on target cells.

Authors:  A Takami; W Zeng; H Wang; T Matsuda; S Nakao
Journal:  Br J Haematol       Date:  1999-12       Impact factor: 6.998

9.  Two populations of erythroid cell progenitors in paroxysmal nocturnal hemoglobinuria.

Authors:  B Rotoli; R Robledo; N Scarpato; L Luzzatto
Journal:  Blood       Date:  1984-10       Impact factor: 22.113

10.  Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.

Authors:  J Takeda; T Miyata; K Kawagoe; Y Iida; Y Endo; T Fujita; M Takahashi; T Kitani; T Kinoshita
Journal:  Cell       Date:  1993-05-21       Impact factor: 41.582
View more
  19 in total

1.  Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH).

Authors:  Norimitsu Inoue; Tomohisa Izui-Sarumaru; Yoshiko Murakami; Yuichi Endo; Jun-Ichi Nishimura; Ken Kurokawa; Maki Kuwayama; Hiroaki Shime; Takashi Machii; Yuzuru Kanakura; Gabrielle Meyers; Carl Wittwer; Zhong Chen; William Babcock; Debra Frei-Lahr; Charles J Parker; Taroh Kinoshita
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

2.  CRISPR/Cas9 PIG -A gene editing in nonhuman primate model demonstrates no intrinsic clonal expansion of PNH HSPCs.

Authors:  Tae-Hoon Shin; Eun Jung Baek; Marcus A F Corat; Shirley Chen; Jean-Yves Metais; Aisha A AlJanahi; Yifan Zhou; Robert E Donahue; Kyung-Rok Yu; Cynthia E Dunbar
Journal:  Blood       Date:  2019-04-19       Impact factor: 22.113

Review 3.  Immunologic aspects of hypoplastic myelodysplastic syndrome.

Authors:  Rodrigo T Calado
Journal:  Semin Oncol       Date:  2011-10       Impact factor: 4.929

4.  The evolution of paroxysmal nocturnal haemoglobinuria depends on intensity of immunosuppressive therapy.

Authors:  Taha Bat; Omnia N Abdelhamid; Suresh K Balasubramanian; Aly Mai; Tomas Radivoyevitch; Michael Clemente; Jaroslaw P Maciejewski
Journal:  Br J Haematol       Date:  2017-08-14       Impact factor: 6.998

Review 5.  Molecular genetics of paroxysmal nocturnal hemoglobinuria.

Authors:  Norimitsu Inoue; Yoshiko Murakami; Taroh Kinoshita
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

Review 6.  Clinical implications of somatic mutations in aplastic anemia and myelodysplastic syndrome in genomic age.

Authors:  Jaroslaw P Maciejewski; Suresh K Balasubramanian
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

7.  Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome.

Authors:  Jibran Durrani; Jaroslaw P Maciejewski
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 8.  Expanding Complement Therapeutics for the Treatment of Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Dimitrios C Mastellos; Edimara S Reis; Despina Yancopoulou; Antonio M Risitano; John D Lambris
Journal:  Semin Hematol       Date:  2018-02-14       Impact factor: 3.851

Review 9.  Paroxysmal nocturnal haemoglobinuria.

Authors:  Anita Hill; Amy E DeZern; Taroh Kinoshita; Robert A Brodsky
Journal:  Nat Rev Dis Primers       Date:  2017-05-18       Impact factor: 52.329

10.  Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.

Authors:  Antonio M Risitano; Bruno Rotoli
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.